Lawsuit concerns Teva's application for approval to market Levitra for the treatment of erectile dysfunction
Multaq to treat patients with atrial fibrillation or atrial flutter
Dow To Streamline Manufacturing Footprint
Calls for shutdown of a number of manufacturing assets, including ethylene and ethylene-derivative assets
Myriad Genetics Spins Off Research, Pharmaceutical Business
Myriad Genetics to claim approximately $400 million in tax deductions
GSK Extends Product Portfolio In Middle East, North Africa
Business comprises a portfolio of 13 branded pharmaceuticals
Biogen Idec, Acorda Sign Collaboration Agreement For Fampridine-SR
Acorda to continue developing and commercializing Fampridine-SR in the US